HROWHarrow, Inc.
$29.36-34% 1Y
$29.36
$29.0352 weeks$54.80
The financials
Harrow, Inc. by the numbers
Harrow, Inc. (HROW) reported revenue of $71M in Q2 2026 (quarter ended Jun 30, 2026), up 11% from the same quarter a year earlier. That came with a gross margin of 71% and net loss of $17M. For the full year FY2025, revenue was $272M (+36% year on year) and net income −$5.1M. Its largest product in Q2 2026 was Product Sales Net at $71M, 100% of the disclosed total, well ahead of Other at 0.1%. The next results filing is expected around Nov 9, 2026, the same week as a year ago.
| Income statement | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Revenue | $71M | $64M | +11% |
| Gross profit | $50M | $48M | +6.0% |
| Operating income | −$11M | $11M | to a loss |
| Net income | −$17M | $5.0M | to a loss |
| Diluted EPS | −$0.46 | $0.13 | to a loss |
| Product | Revenue | Share |
|---|---|---|
| Product Sales Net | $71M | 100% |
| Other | $90K | 0.1% |
Business segments
Revenue split by product segment, from SEC XBRL filings.
Latest period: Jun 2026Total $70.7M (+60%)
Product Sales Net grew +11% year on yearOther +5.9% year on year
Segment Latestquarter on quarteryear on year
- Product Sales Net$70.6M$70.6Mquarter on quarter +60%year on year +11%+60%+11%
- Other$90.0K$90.0Kquarter on quarter +23%year on year +5.9%+23%+5.9%
On our screens:Most shorted stocks
Drug Manufacturers, Specialty & Generic
Ranks #22 of 41 by RyuScore